Skip to content

Study · Not a test of the peptide alone · 1987

2 results

Degradation and aggregation of delta sleep-inducing peptide (DSIP) and two analogs in plasma and serum.

Graf MV, Saegesser B, Schoenenberger GA

Peptides1 Jul 1987Cited by 5 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Delta sleep-inducing peptide (DSIP).

  1. 01LabNot a test of Delta sleep-inducing peptide (DSIP) aloneEx vivo tissuePharmacokinetics

    In human or rat blood incubations, DSIP was degraded and released products that eluted on gel filtration like tryptophan.

    In plain wordsIn lab tests with human or rat blood, DSIP broke down and released a product that behaved like tryptophan.

    Outcome
    Not applicableDSIP degradation in blood
    Study

    human, ratn: not reported in source

    blood
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    Incubation of DSIP in human or rat blood led to release of products having retention times on a gel filtration column equivalent to Trp.
    1 context sentence
    Summary · context
    The biostability of DSIP (delta sleep-inducing peptide) and two analogs in blood was investigated in order to determine if rates of inactivation contribute to variable effects in vivo.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  2. 02LabNot a test of Delta sleep-inducing peptide (DSIP) aloneEx vivo tissuePharmacokinetics

    In blood incubations, formation of DSIP degradation products depended on temperature, time and species.

    In plain wordsIn lab tests with blood, how much DSIP broke down depended on temperature, time and species.

    Outcome
    Not applicableDependence of DSIP degradation on temperature, time and species
    Study

    human, ratn: not reported in source

    blood
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    Formation of products was dependent on temperature, time, and species.
    1 context sentence
    Summary · context
    The biostability of DSIP (delta sleep-inducing peptide) and two analogs in blood was investigated in order to determine if rates of inactivation contribute to variable effects in vivo.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.